Skip to main content

Peer Review reports

From: Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations

Original Submission
28 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Oct 2022 Reviewed Reviewer Report
5 Nov 2022 Reviewed Reviewer Report
21 Nov 2022 Author responded Author comments - Rongchang Chen
Resubmission - Version 3
21 Nov 2022 Submitted Manuscript version 3
23 Nov 2022 Author responded Author comments - Rongchang Chen
Resubmission - Version 4
23 Nov 2022 Submitted Manuscript version 4
30 Nov 2022 Author responded Author comments - Rongchang Chen
Resubmission - Version 5
30 Nov 2022 Submitted Manuscript version 5
5 Dec 2022 Reviewed Reviewer Report
1 Jan 2023 Reviewed Reviewer Report
21 Jan 2023 Author responded Author comments - Rongchang Chen
Resubmission - Version 6
21 Jan 2023 Submitted Manuscript version 6
28 Jan 2023 Author responded Author comments - Rongchang Chen
Resubmission - Version 7
28 Jan 2023 Submitted Manuscript version 7
10 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
21 Feb 2023 Editorially accepted
31 Mar 2023 Article published 10.1186/s12890-023-02364-0

You can find further information about peer review here.

Back to article page